HER2
Clinical trials for HER2 explained in plain language.
Never miss a new study
Get alerted when new HER2 trials appear
Sign up with your email to follow new studies for HER2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced colon cancer: combo therapy targets tumors after standard treatment fails
Disease control Not yet recruitingThis study tests a new drug combination (SHR-1811 plus bevacizumab) as a second-line treatment for people with metastatic colorectal cancer that has worsened after initial chemotherapy. About 80 adults aged 18-75 will participate to see if the combo shrinks tumors or slows cancer…
Matched conditions: HER2
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New PET tracer aims to sharpen view of HER2 cancers
Diagnosis Not yet recruitingThis early-phase study will test a radioactive tracer called [68Ga]Ga-ABY-025 during PET scans to see if it can better identify HER2-positive tumors in people with advanced or metastatic cancer. About 30 adults who are already receiving standard HER2-targeted therapy will receive…
Matched conditions: HER2
Phase: EARLY_PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated May 01, 2026 16:00 UTC